Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)
Phase 4
Completed
- Conditions
- HIV-1-infection
- Interventions
- Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (FDC)
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- The Crofoot Research Center, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT04388904
- Locations
- 🇺🇸
The Crofoot Research Center, Inc., Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath